home / stock / vtyx / vtyx short
Short Information | Ventyx Biosciences Inc. (NASDAQ:VTYX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,136,360 |
Total Actual Volume | 18,073,658 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 106,818 |
Average Short Percentage | 11.67% |
Is there a VTYX Short Squeeze or Breakout about to happen?
See the VTYX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-09-2024 | $4.5 | $4.48 | $4.63 | $4.38 | 545,104 | 86,187 | 15.81% |
05-08-2024 | $4.51 | $4.44 | $4.62 | $4.4 | 377,701 | 41,703 | 11.04% |
05-07-2024 | $4.74 | $4.605 | $4.87 | $4.57 | 342,916 | 34,467 | 10.05% |
05-06-2024 | $4.9 | $4.71 | $4.995 | $4.6197 | 433,687 | 45,309 | 10.45% |
05-03-2024 | $5.05 | $4.85 | $5.24 | $4.85 | 853,274 | 137,209 | 16.08% |
05-02-2024 | $4.76 | $4.91 | $5.17 | $4.5638 | 1,909,345 | 284,118 | 14.88% |
05-01-2024 | $3.78 | $4.68 | $4.9125 | $3.7 | 2,269,491 | 393,747 | 17.35% |
04-30-2024 | $3.8 | $3.74 | $3.96 | $3.7 | 2,856,835 | 161,084 | 5.64% |
04-29-2024 | $3.94 | $3.835 | $4.045 | $3.82 | 947,340 | 88,474 | 9.34% |
04-26-2024 | $4.04 | $3.93 | $4.08 | $3.925 | 529,730 | 37,148 | 7.01% |
04-25-2024 | $4.15 | $4.06 | $4.15 | $3.94 | 586,706 | 67,663 | 11.53% |
04-24-2024 | $4.32 | $4.24 | $4.45 | $4.22 | 375,984 | 32,292 | 8.59% |
04-23-2024 | $4.34 | $4.35 | $4.42 | $4.26 | 444,784 | 45,466 | 10.22% |
04-22-2024 | $4.5 | $4.3 | $4.54 | $4.23 | 1,100,280 | 108,415 | 9.85% |
04-19-2024 | $4.33 | $4.47 | $4.63 | $4.26 | 906,049 | 130,429 | 14.4% |
04-18-2024 | $4.37 | $4.35 | $4.48 | $4.235 | 849,902 | 104,630 | 12.31% |
04-17-2024 | $4.76 | $4.38 | $4.7683 | $4.36 | 780,158 | 106,603 | 13.66% |
04-16-2024 | $4.62 | $4.76 | $4.82 | $4.55 | 661,262 | 77,573 | 11.73% |
04-15-2024 | $4.64 | $4.67 | $4.83 | $4.595 | 628,944 | 67,849 | 10.79% |
04-12-2024 | $4.57 | $4.6 | $4.68 | $4.5 | 674,166 | 85,994 | 12.76% |
News, Short Squeeze, Breakout and More Instantly...
Ventyx Biosciences Inc. Company Name:
VTYX Stock Symbol:
NASDAQ Market:
Phase 2a trials of CNS-Penetrant NLRP3 Inhibitor VTX3232 to initiate in H2 2024 in patients with early Parkinson’s disease and in participants with obesity with certain additional cardiovascular risk factors Cash, cash equivalents and marketable securities of $302.6 million as ...
SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX), ("Ventyx"), a clinical-stage biopharmaceutical company focus...
SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced th...